Fidelity Investments’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$198M Buy
2,527,936
+42,179
+2% +$3.3M 0.01% 821
2025
Q1
$180M Buy
2,485,757
+57,014
+2% +$4.13M 0.01% 831
2024
Q4
$180M Buy
2,428,743
+579,541
+31% +$42.9M 0.01% 866
2024
Q3
$122M Sell
1,849,202
-5,773,245
-76% -$381M 0.01% 1017
2024
Q2
$704M Sell
7,622,447
-617,049
-7% -$57M 0.05% 336
2024
Q1
$787M Buy
8,239,496
+737,442
+10% +$70.5M 0.05% 324
2023
Q4
$572M Buy
7,502,054
+4,390,669
+141% +$335M 0.04% 379
2023
Q3
$216M Buy
3,111,385
+1,179,637
+61% +$81.7M 0.02% 661
2023
Q2
$182M Buy
1,931,748
+87,431
+5% +$8.25M 0.02% 752
2023
Q1
$153M Sell
1,844,317
-133,167
-7% -$11M 0.01% 825
2022
Q4
$148M Sell
1,977,484
-4,643,634
-70% -$346M 0.01% 813
2022
Q3
$547M Sell
6,621,118
-2,240,274
-25% -$185M 0.06% 325
2022
Q2
$843M Buy
8,861,392
+1,244,420
+16% +$118M 0.08% 221
2022
Q1
$897M Sell
7,616,972
-743,404
-9% -$87.5M 0.07% 259
2021
Q4
$1.08B Sell
8,360,376
-356,322
-4% -$46.2M 0.08% 221
2021
Q3
$987M Buy
8,716,698
+1,180,500
+16% +$134M 0.08% 228
2021
Q2
$781M Buy
7,536,198
+2,358,602
+46% +$244M 0.06% 291
2021
Q1
$433M Sell
5,177,596
-3,616,929
-41% -$303M 0.04% 474
2020
Q4
$802M Sell
8,794,525
-2,114,677
-19% -$193M 0.07% 264
2020
Q3
$871M Sell
10,909,202
-1,456,930
-12% -$116M 0.09% 208
2020
Q2
$855M Sell
12,366,132
-6,444,663
-34% -$445M 0.09% 191
2020
Q1
$1.18B Sell
18,810,795
-5,466,930
-23% -$344M 0.16% 115
2019
Q4
$1.89B Buy
24,277,725
+1,330,245
+6% +$103M 0.21% 88
2019
Q3
$1.68B Sell
22,947,480
-900,684
-4% -$66M 0.2% 91
2019
Q2
$1.47B Sell
23,848,164
-679,224
-3% -$41.8M 0.17% 105
2019
Q1
$1.56B Buy
24,527,388
+1,796,928
+8% +$115M 0.19% 103
2018
Q4
$1.16B Buy
22,730,460
+5,100,597
+29% +$260M 0.16% 118
2018
Q3
$1.02B Sell
17,629,863
-2,514,189
-12% -$146M 0.12% 162
2018
Q2
$977M Buy
20,144,052
+4,990,533
+33% +$242M 0.11% 172
2018
Q1
$705M Buy
15,153,519
+12,723,201
+524% +$592M 0.08% 255
2017
Q4
$91.3M Buy
2,430,318
+189,261
+8% +$7.11M 0.01% 1037
2017
Q3
$81.7M Sell
2,241,057
-405,738
-15% -$14.8M 0.01% 1065
2017
Q2
$104M Sell
2,646,795
-2,156,940
-45% -$85M 0.01% 967
2017
Q1
$151M Sell
4,803,735
-15,837,690
-77% -$497M 0.02% 816
2016
Q4
$645M Sell
20,641,425
-11,547,552
-36% -$361M 0.09% 252
2016
Q3
$1.29B Sell
32,188,977
-4,910,787
-13% -$197M 0.17% 115
2016
Q2
$1.23B Buy
37,099,764
+425,139
+1% +$14.1M 0.17% 128
2016
Q1
$1.08B Buy
36,674,625
+8,865,105
+32% +$261M 0.15% 141
2015
Q4
$732M Buy
27,809,520
+11,459,376
+70% +$302M 0.1% 214
2015
Q3
$387M Buy
16,350,144
+4,215,504
+35% +$99.9M 0.06% 379
2015
Q2
$288M Sell
12,134,640
-8,916,450
-42% -$212M 0.04% 517
2015
Q1
$500M Sell
21,051,090
-3,149,382
-13% -$74.8M 0.06% 346
2014
Q4
$514M Sell
24,200,472
-5,575,560
-19% -$118M 0.07% 328
2014
Q3
$507M Sell
29,776,032
-10,615,320
-26% -$181M 0.07% 310
2014
Q2
$578M Sell
40,391,352
-5,616,246
-12% -$80.3M 0.08% 293
2014
Q1
$569M Buy
46,007,598
+28,778,196
+167% +$356M 0.08% 277
2013
Q4
$189M Buy
17,229,402
+11,175,360
+185% +$122M 0.03% 661
2013
Q3
$70.3M Buy
6,054,042
+263,634
+5% +$3.06M 0.01% 1115
2013
Q2
$64.9M Buy
+5,790,408
New +$64.9M 0.01% 1117